Page - (000267) - in Biomedical Chemistry: Current Trends and Developments

Liskamp, R. M. J. (2014). Bicycling into cells. Nature Chemistry, 6, 855-857. Loffet, A. (2002). Peptides as drugs: is there a market? Journal of Peptide Sciences, 8, 1-7. Loo, Y.; Zhang, S.; Hauser, C. A. E. (2012). From short peptides to nanofibers to macromolecular assemblies in biomedicine. Biotechnology Advances, 30, 593-603. Lowenberger, C. (2001). Innate immune response of Aedes aegypti. Insect Biochemistry and Molecular Biology, 31, 219-229. Ludtke, S. J.; He, K.; Heller, W. T.; Harroun, T. A.; Yang, L.; Huang H. W. (1996). Membrane pores induced by magainin. Biochemistry, 35, 13723-13728. Ma, J. S. (2003). Unnatural amino acids in drug discovery. Chimica Oggi, 21, 65-68. Manna, P.; Sinha, M.; Sil, P. C. (2009). Taurine plays a beneficial role against cadmium-induced oxidative renal dysfunction. Amino Acids, 36, 417-428. Mandal, D.; Shirazi, A. N.; Parang, K. (2011). Cell-penetrating homochiral cyclic peptides as nuclear-targeting molecular transporters. Angewandte Chemie International Edition, 50, 9633-9637. Marathe, P. H.; Kamath, A. V.; Zhang, Y.; D’Arienzo, C.; Bhide, R.; Fargnoli, J. (2009). Preclinical pharmacokinetics and in vitro metabolism of brivanib (BMS-540215), a potent VEGFR2 inhibitor and its alanine ester prodrug brivanib alaninate. Cancer Chemotherapy and Pharmacology, 65, 55-66. Mart, R. J.; Osborne, R. D.; Stevens, M. M.; Ulijn, R. V. (2006). Peptide-based stimuli-responsive biomaterials. Soft Matter, 2, 822-835. Mason, A. J.; Moussaoui, W.; Abdelrahman, T.; Boukhari, A.; Bertani, P.; Marquette A.; Shooshtarizaheh, P.; Moulay, G.; Boehm, N.; Guerold, B.; Sawers, R. J.; Kichler A.; Metz- Boutigue, M. H.; Candolfi, E.; Prévost, G.; Bechinger, B. (2009). Structural determinants of antimicrobial and antiplasmodial activity and selectivity in histidine-rich amphipathic cationic peptides. Journal of Biological Chemistry, 284, 119-133. Matson, J. B.; Zha, R. H.; Stupp, S.I. (2011). Peptide self-assembly for crafting functional biological materials. Current Opinion in Solid State and Materials Science, 15, 225-235. Matson, J. B.; Stupp, S. I. (2012). Self-assembling peptide scaffolds for regenerative medicine. Chemical Communications, 48, 26-33. McGregor, D. P. (2008). Discovering and improving novel peptide therapeutics. Current Opinion in Pharmacology, 8, 616-619. Melo, M. N.; Ferre, R.; Castanho, M. A. (2009). Antimicrobial peptides: linking partition, activity and high membrane-bound concentrations, Nature Review Microbiology, 7, 245-250. Milletti, F. (2012). Cell-penetrating peptides: classes, origin, and current landscape. Drug Discovery Today, 17, 850-860. Miranda, P.; Blum, M. R. (1983). Pharmacokinetics of acyclovir after intravenous and oral administration, J. Antimicrobial Agents Chemotherapy, 12(Suppl. B), 29-37. Mittal, S.; Song, X.; Vig, B. S.; Amidon, G. L. (2007). Proline prodrug of melphalan targeted to prolidase, a prodrug activating enzyme overexpressed in melanoma. Pharmaceutical Research, 24, 1290-1298. Mizuma, T.; Ohta, K.; Hayashi, M.; Awazu, S. (1992). Intestinal active absorption of sugar- conjugated compounds by glucose transport system: implication of improvement of poorly absorbable drugs. Biochemical Pharmacology, 43, 2037-2039.